logo_new@0,75x
  • Glycotest
  • About us
    • Management Team and Board
    • Scientific and Medical Advisors
    • Glycotest Investor Presentation
    • Investors
  • Technology
    • Clinical Data
    • Intellectual Property
  • News
  • Contact us
glycotest_logo
logo_new@0,75x
  • Glycotest
  • About us
    • Management Team and Board
    • Scientific and Medical Advisors
    • Glycotest Investor Presentation
    • Investors
  • Technology
    • Clinical Data
    • Intellectual Property
  • News
  • Contact us

Glycotest is developing a new Test for Detecting Early Stage Liver Cancer with the revolutionary approach of using Glycoproteins as Biomarkers – CEOCFO Magazine

September 3, 2019
-
News
-
No comments
-
Posted by Webmaster

Glycotest19-CEOCFOMagazine-Interview.pdf

← PREVIOUS POST
Glycotest, Inc. Receives $3 Million Second Tranche of $10 Million Series A Financing
NEXT POST →
Glycotest was chosen as one of 50 companies to be in the MedTech Showcase in September 2019

Leave a Comment

Your feedback is valuable for us. Your email will not be published.
Cancel Reply

Please wait...
Submit Comment

Related News

Other posts that you should not miss.
Glycotest’s Patent Portfolio Covering Detection of Serious Liver Disease Expanded by Grant of European Patent.

Glycotest’s Patent Portfolio Covering Detection of Serious Liver Disease Expanded by Grant of European Patent

January 13, 2021
-
News
Read More →
Posted by glycotest
1 MIN READ
Six new patents protecting Glycotest’s HCC Panel test have been issued or allowed in the United States, Europe, China, Taiwan, Japan, and Mexico.

Six new patents protecting Glycotest’s HCC Panel test have been issued or allowed in the United States, Europe, China, Taiwan, Japan, and Mexico

March 1, 2023
-
News
Read More →
Posted by glycotest
1 MIN READ
Glycotest Third Party Fundraise

Glycotest Third Party Fundraise

May 3, 2023
-
News
Read More →
Posted by glycotest
1 MIN READ

GET IN TOUCH

Give Us A Call

+1 484-431-3483

Send Us A Message

info@glycotest.com

Copyright© All Rights Reserved
Website Designed & Developed by Jason and Company
Glycotest is developing a new Test for Detecting Early Stage Liver Cancer with the revolutionary approach of using Glycoproteins as Biomarkers – CEOCFO Magazine | Glycotest Diagnostics